$LHDX News
Last published 3y ago
- 3y agoLHDXLucira Health Announces FDA Authorization of First & Only At-Home Combination Covid-19 & Flu Test and Comments on Chapter 11 Bankruptcy FilingGlobeNewswireLab-quality results for both COVID-19 and Flu now available at home from one single testCOVID-19 and Flu have similar symptoms but different treatments, requiring a fast, differential test to access time-sensitive
- 3y agoLHDXLucira Health to Pursue Strategic Sale of its Business Through Voluntary Chapter 11 ProcessGlobeNewswireEMERYVILLE, Calif., Feb. 22, 2023 (GLOBE NEWSWIRE) -- Lucira Health, Inc. (NASDAQ:LHDX) ("Lucira Health," "Lucira" or the "Company"), a medical technology company, announced today that it has filed for protection under
- 3y agoLHDXSESAME PARTNERS WITH LUCIRA HEALTH AS OFFICIAL TELEHEALTH PROVIDER OF LAB-QUALITY TEST-TO-TREAT PROGRAMPR NewswireNew partnership enables a free Sesame telehealth consultation with purchase of a Lucira at-home COVID-19 test, providing a full test-to-treat experience from the comfort of home, within two hours NEW YORK , Jan. 5, 2023
- 3y agoLHDXLucira Health Launches Lucira Connect, a Free Test-to-Treat Telehealth Service for Covid-19 or Flu in CanadaGlobeNewswireFor $98 CAD Canadians will receive a free telehealth appointment included with purchase of a testLucira Connect provides lab-quality at-home test-users a telehealth visit at no additional cost, enabling Test-to-Treatment
- 3y agoLHDXLucira Health Submits EUA for Over-The-Counter (OTC) Use of its COVID-19 & Flu TestGlobeNewswireEMERYVILLE, Calif., Jan. 03, 2023 (GLOBE NEWSWIRE) -- Lucira Health, Inc. (NASDAQ:LHDX) ("Lucira Health" or "Lucira"), a medical technology company, announced that it submitted an Emergency Use
- 3y agoLHDXLucira and Loch Lomond Villa Announce Clinical Study to Tackle Tripledemic With First and Only Combination COVID-19 and Flu OTC Molecular Self-TestGlobeNewswireLucira COVID-19 & Flu Test is the first and only combination over-the-counter (OTC) self-test with fast, molecular lab-quality results enabling mass testing of symptomatic residents, staff and visitors amid the
- 3y agoLHDXLucira Health Announces FDA Authorization of Combination COVID-19 & Flu Test at Point-of-CareGlobeNewswirePCR Lab-quality NAAT/molecular test for both COVID-19 and flu from 1 shallow nasal swabPositive result as quickly as 11 minutes, negative result in 30 minutes, allowing diagnosis during patient visitEquipment-free Lucira
- 3y agoLHDXLucira Health Announces National Launch of Lucira Connect Test-to-Treat ServiceGlobeNewswireDigital health service offers Lucira lab-quality at-home test users a telehealth visit at no additional cost, enabling Test-to-Treatment within hours for only $29, excluding prescription costsLucira partners with Pfizer
- 3y agoLHDXLucira Health Announces Third Quarter 2022 Results and Provides Business UpdatesGlobeNewswireEMERYVILLE, Calif., Nov. 14, 2022 (GLOBE NEWSWIRE) -- Lucira Health, Inc. (NASDAQ:LHDX) ("Lucira Health," "Lucira" or the "Company"), a medical technology company focused on the development and
- 4y agoLHDXLucira Health to Announce Third Quarter 2022 Financial ResultsGlobeNewswireEMERYVILLE, Calif., Nov. 01, 2022 (GLOBE NEWSWIRE) -- Lucira Health, Inc. ("Lucira Health" or "Lucira"), a medical technology company focused on the development and commercialization of transformative and innovative
- 4y agoLHDXLucira Health Reports Pilot Study Interim Results for Chlamydia and Gonorrhea AssaysGlobeNewswireEMERYVILLE, Calif., Sept. 29, 2022 (GLOBE NEWSWIRE) -- Lucira Health, Inc. (NASDAQ:LHDX) ("Lucira Health" or "Lucira"), a medical technology company, today announced interim results of a pilot study to evaluate the performance of their combined Chlamyd
- 4y agoLHDXLucira Health to Participate in LifeSci Partners HealthTech SymposiumGlobeNewswireEMERYVILLE, Calif., Sept. 07, 2022 (GLOBE NEWSWIRE) -- Lucira Health, Inc. ("Lucira Health" or "Lucira"), a medical technology company focused on the development and commercialization of transformative and innovative infectious disease test kits, and
- 4y agoLHDXLucira Health to Present at the Inaugural Gilmartin Group Emerging Growth Company ShowcaseGlobeNewswireEMERYVILLE, Calif., Aug. 23, 2022 (GLOBE NEWSWIRE) -- Lucira Health, Inc. ("Lucira Health" or "Lucira"), a medical technology company focused on the development and commercialization of transformative and innovative infectious disease test kits, today
- 4y agoLHDXLucira Health Announces Second Quarter 2022 Results and Provides Business UpdatesGlobeNewswireEMERYVILLE, Calif., Aug. 15, 2022 (GLOBE NEWSWIRE) -- Lucira Health, Inc. (NASDAQ:LHDX) ("Lucira Health," "Lucira" or the "Company"), a medical technology company focused on the development and commercialization of transformative and innovative infecti
- 4y agoLHDXLucira Health, Inc. (LHDX) Q2 2022 Earnings Call TranscriptEarnings Call TranscriptsLHDX earnings call for the period ending June 30, 2022.
- 4y agoLHDXLucira Announces Health Canada Authorization of First and Only 99% Accurate At-Home Covid & Flu TestGlobeNewswireEMERYVILLE, Calif., Aug. 11, 2022 (GLOBE NEWSWIRE) -- Lucira Health, Inc. (NASDAQ:LHDX) ("Lucira Health," "Lucira" or the "Company"), a medical technology company focused on the development and commercialization of transformative and innovative infecti
- 4y agoLHDXLucira Health to Announce Second Quarter 2022 Financial ResultsGlobeNewswireEMERYVILLE, Calif., Aug. 02, 2022 (GLOBE NEWSWIRE) -- Lucira Health, Inc. ("Lucira Health" or "Lucira"), a medical technology company focused on the development and commercialization of transformative and innovative infectious disease test kits, today
- 4y agoLHDXLucira Health Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)GlobeNewswireEMERYVILLE, Calif., Aug. 01, 2022 (GLOBE NEWSWIRE) -- Lucira Health, Inc. ("Lucira Health" or "Lucira") (NASDAQ:LHDX), a medical technology company focused on the development and commercialization of innovative infectious disease tests today announced
- 4y agoLHDXLucira Health Announces First Quarter 2022 Results and Business UpdateGlobeNewswireEMERYVILLE, Calif., May 12, 2022 (GLOBE NEWSWIRE) -- Lucira Health, Inc. (NASDAQ:LHDX) ("Lucira Health," "Lucira" or the "Company"), a medical technology company focused on the development and commercialization of transformative and innovative infectio
- 4y agoLHDXLucira Health, Inc. (LHDX) Q1 2022 Earnings Call TranscriptEarnings Call TranscriptsLHDX earnings call for the period ending March 31, 2022.
- 4y agoLHDXLucira Files for Authorization of First-of-its-Kind COVID-19 & Flu At-Home Molecular TestGlobeNewswireEMERYVILLE, Calif., May 12, 2022 (GLOBE NEWSWIRE) -- Lucira Health, Inc. ("Lucira Health" or "Lucira") (NASDAQ:LHDX), a medical technology company focused on the development and commercialization of innovative infectious disease tests, announced today
- 4y agoLHDXLucira Receives CE Mark for both COVID-19 & Flu and COVID-19 Molecular TestsGlobeNewswireEMERYVILLE, Calif., May 09, 2022 (GLOBE NEWSWIRE) -- Lucira Health, Inc. ("Lucira Health" or "Lucira") (NASDAQ:LHDX), a medical technology company focused on the development and commercialization of innovative infectious disease tests, announced that b
- 4y agoLHDXLucira Health to Participate in Bank of America 2022 Healthcare ConferenceGlobeNewswireEMERYVILLE, Calif., May 04, 2022 (GLOBE NEWSWIRE) -- Lucira Health, Inc. ("Lucira Health" or "Lucira"), a medical technology company focused on the development and commercialization of transformative and innovative infectious disease test kits, today a
- 4y agoLHDXLucira Health to Announce First Quarter 2022 Financial ResultsGlobeNewswireEMERYVILLE, Calif., April 28, 2022 (GLOBE NEWSWIRE) -- Lucira Health, Inc. ("Lucira Health" or "Lucira"), a medical technology company focused on the development and commercialization of transformative and innovative infectious disease test kits, today
- 4y agoLHDXLUCIRA HEALTH AND USA BOXING ANNOUNCE EXCLUSIVE PARTNERSHIP FOR THE 2022 SEASONPR NewswireLucira is the official COVID-19 test provider of USA Boxing athletes and staff and will commit $5 of support to the organization for each test purchased by fans EMERYVILLE, Calif., April 21, 2022 /PRNewswire/ -- Lucira Health, Inc. ("Lucira Health" or
- 4y agoLHDXLucira Health Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)GlobeNewswireEMERYVILLE, Calif., April 11, 2022 (GLOBE NEWSWIRE) -- Lucira Health, Inc. (NASDAQ:LHDX), a medical technology company focused on the development and commercialization of transformative and innovative infectious disease test kits, today announced that
- 4y agoLHDXLucira Donates Rapid Molecular At-Home COVID-19 Test Kits to Protect the Safety of Tonga Red Cross Society WorkersPR NewswireCOVID-19 Comes to Isolated Pacific Island of Tonga And Cases Soar After Volcanic Eruption and Tsunami EMERYVILLE, Calif., March 31, 2022 /PRNewswire/ -- Lucira Health, Inc. ("Lucira Health" or "Lucira") (NASDAQ:LHDX), a medical technology company foc
- 4y agoLHDXLucira Health's COVID-19 & Flu At-Home Molecular Test Shows Positive Clinical Study ResultsPR NewswireCOVID-19 and Influenza (flu) have similar symptoms, as well as effective but distinct treatments, making tests to differentiate between these infections crucial The Lucira COVID-19 & Flu test is a single at-home molecular test designed to independently
- 4y agoLHDXLucira Health's PCR-Quality At-Home COVID-19 Test Now Available Direct to Consumers in CanadaPR NewswireLucira's molecular test provides PCR-quality results in 30 minutes in a simple single-use test Lucira was the first at-home COVID-19 test authorized in Canada and has been used in public health programs and for safe travel EMERYVILLE, Calif., March 2
- 4y agoLHDXLucira Health Announces Fourth Quarter and Full Year 2021 Results and Reaffirms 2022 Financial OutlookGlobeNewswireEMERYVILLE, Calif., March 10, 2022 (GLOBE NEWSWIRE) -- Lucira Health, Inc. (NASDAQ:LHDX) ("Lucira Health," "Lucira" or the "Company"), a medical technology company focused on the development and commercialization of transformative and innovative infect
- 4y agoLHDXLucira Health, Inc. (LHDX) Q4 2021 Earnings Call TranscriptEarnings Call TranscriptsLHDX earnings call for the period ending December 31, 2021.
- 4y agoLHDXLucira Health to Announce Fourth Quarter 2021 Financial ResultsGlobeNewswireEMERYVILLE, Calif., Feb. 28, 2022 (GLOBE NEWSWIRE) -- Lucira Health, Inc. ("Lucira Health" or "Lucira") (NASDAQ:LHDX), a medical technology company focused on the development and commercialization of transformative and innovative infectious disease tes
- 4y agoHTGCLHDXSIVBLucira Health Secures Debt Facility of Up to $80 Million from Hercules Capital and Silicon Valley BankGlobeNewswireEMERYVILLE, Calif., Feb. 08, 2022 (GLOBE NEWSWIRE) -- Lucira Health, Inc. ("Lucira Health" or "Lucira") (NASDAQ:LHDX), a medical technology company focused on the development and commercialization of transformative and innovative infectious disease tes
- 4y agoLHDXLucira™ Health Commits 2 Million At-Home Molecular COVID-19 Test Kits on AmazonPR NewswireEMERYVILLE, Calif., Feb. 3, 2022 /PRNewswire/ -- Lucira Health, Inc. ("Lucira Health" or "Lucira") (NASDAQ:LHDX), a medical technology company focusing on the development and commercialization of transformative and innovative infectious disease test kits
- 4y agoLHDXLucira™ Check-It PCR-Quality, At-Home Molecular COVID-19 Test Now Available in the Optum StoreGlobeNewswireLucira's COVID-19 test is the only EUA authorized rapid at-home self-test that delivers PCR accuracy and early detectability in a single-use test kit with results in 30 minutes Availability in the Optum Store expands access to this unique testing o
- 4y agoLHDXLucira Health Reports Preliminary Revenue Results for Fourth Quarter and Full Year 2021 and Provides Business UpdateGlobeNewswireEMERYVILLE, Calif., Jan. 10, 2022 (GLOBE NEWSWIRE) -- Lucira Health, Inc. ("Lucira") (NASDAQ:LHDX), a medical technology company focused on the development and commercialization of transformative and innovative infectious disease test kits, today annou
- 4y agoLHDXLucira Health and Co-Defend/Co-Protect Announce Expanded Partnership for 2022GlobeNewswireLucira is the only EUA authorized at-home self-test kit that delivers PCR-quality accuracy and early detectability in a single-use test kit with results in 30 minutes Co-Defend and Co-Protect are leading providers of customized health & safety solution
- 4y agoLHDXLucira Health Announces Expanded Partnership with Switch Health to Increase Canadians' Access to At-Home Molecular COVID-19 TestsGlobeNewswireLucira's tests are the only available at-home self-test kits that deliver PCR-quality accuracy and early detectability in a single-use test kit with results in 30 minutes Current surge of COVID-19 cases caused by the Omicron variant highlights the need
- 4y agoLHDXLucira's at Home Molecular Tests Can Detect Omicron (B.1.1.529) SARS CoV-2 Variant of ConcernGlobeNewswireLucira assessment confirms COVID-19 Check-It (OTC) and All-In-One (Rx) molecular self-test kits' ability to detect 100% of Omicron variant genome sequences analyzed Lucira assays target viral sequence regions unaffected by the spike protein mutations f
- 5y agoLHDXLucira Health Announces Third Quarter 2021 Financial Results and Provides Business UpdateGlobeNewswireEMERYVILLE, Calif., Nov. 11, 2021 (GLOBE NEWSWIRE) -- Lucira Health, Inc. (NASDAQ:LHDX) ("Lucira Health," "Lucira" or the "Company"), a medical technology company focused on the development and commercialization of transformative and innovative infecti
- 5y agoLHDXLucira Health, Inc. (LHDX) Q3 2021 Earnings Call TranscriptEarnings Call TranscriptsLHDX earnings call for the period ending September 30, 2021.
- 5y agoLHDXLUCIRA™ CHECK IT PCR Quality, at Home Molecular COVID-19 Test Kit Now Available on AmazonGlobeNewswireEMERYVILLE, Calif., Nov. 09, 2021 (GLOBE NEWSWIRE) -- Lucira Health, Inc. ("Lucira Health" or "Lucira") (NASDAQ:LHDX), a medical technology company focusing on the development and commercialization of transformative and innovative infectious disease te
- 5y agoLHDXLucira Health to Announce Third Quarter 2021 Financial ResultsGlobeNewswireEMERYVILLE, Calif., Oct. 28, 2021 (GLOBE NEWSWIRE) -- Lucira Health, Inc. ("Lucira Health" or "Lucira"), a medical technology company focused on the development and commercialization of transformative and innovative infectious disease test kits, today
- 5y agoLHDXLUCIRA™ CHECK IT COVID-19 Test Kit is Available for Online PurchaseGlobeNewswireThis FDA Emergency Use Authorization ("EUA") first PCR quality, single-use, COVID-19 at home, self-test kit can again be purchased via the Company's website EMERYVILLE, Calif., Oct. 26, 2021 (GLOBE NEWSWIRE) -- Lucira Health, Inc. ("Lucira Health"
- 5y agoLHDXLUCIRA™ HEALTH COVID-19 Test Approved for Sale in SingaporeGlobeNewswireEMERYVILLE, Calif., Oct. 12, 2021 (GLOBE NEWSWIRE) -- Lucira Health, Inc. ("Lucira Health" or "Lucira") (NASDAQ:LHDX), a medical technology company focusing on the development and commercialization of transformative and innovative infectious disease te
- 5y agoLHDXLUCIRA™ HEALTH Provides Statement on Copan's Recall of its FLOQSwabsGlobeNewswireEMERYVILLE, Calif., Oct. 08, 2021 (GLOBE NEWSWIRE) -- Lucira Health, Inc. ("Lucira Health" or "Lucira") (NASDAQ:LHDX), a medical technology company focused on the development and commercialization of transformative and innovative infectious disease tes
- 5y agoLHDXLUCIRA™ HEALTH Hires Tony Allen as Chief Operations OfficerGlobeNewswireEMERYVILLE, Calif., Sept. 20, 2021 (GLOBE NEWSWIRE) -- Lucira Health, Inc. ("Lucira Health" or "Lucira") (NASDAQ:LHDX), a medical technology company focused on the development and commercialization of transformative and innovative infectious disease te
- 5y agoLHDXLUCIRA™ HEALTH Hires Ghazi Kashmolah as Chief Quality Officer and EVP Regulatory AffairsBusiness WireLife science professional expands Lucira's management team Lucira Health, Inc. ("Lucira Health" or "Lucira") (NASDAQ:LHDX), a medical technology company focused on the development and commercialization of transformative and innovative infectious dise
- 5y agoLHDXLucira Health Announces Second Quarter 2021 Financial ResultsGlobeNewswireEMERYVILLE, Calif., Aug. 12, 2021 (GLOBE NEWSWIRE) -- Lucira Health, Inc. (NASDAQ:LHDX) ("Lucira Health," "Lucira" or the "Company"), a medical technology company focused on the development and commercialization of transformative and innovative infecti
- 5y agoLHDXLucira Health, Inc. (LHDX) Q2 2021 Earnings Call TranscriptEarnings Call TranscriptsLHDX earnings call for the period ending June 30, 2021.